PFAS solutions, hydrogen ventures, and IPO plans [Video]

Synergen Met‘s managing director and CEO, Chris Dunks sat down with Proactive’s Jonathan Jackson to discuss the company’s focus on PFAS (per- and polyfluoroalkyl substances) and its potential IPO.

Synergen Met is dedicated to addressing environmental challenges, particularly the elimination of PFAS, which are harmful chemicals linked to health issues. The company employs advanced technology to break down these substances, ensuring they do not pose long-term environmental threats.

Dunks explained PFAS are synthetic chemicals used in various industrial applications and consumer products. These chemicals are persistent in the environment and have been associated with adverse health effects, prompting increased public and regulatory attention.

Synergen Met’s technology aims to eliminate PFAS through a specialised process that decomposes the chemicals into non-harmful components. The company’s recent partnership with Yokogawa Corporation of America is expected to enhance their capabilities by combining Yokogawa’s expertise in industrial automation with Synergen Met’s innovative solutions, thereby providing more …